<DOC>
	<DOCNO>NCT00038714</DOCNO>
	<brief_summary>Recurrent Respiratory Papillomatosis ( RRP ) cause wart-like lesion along throat area obstruct airway become malignant . The cause relate specific type Human Papillomavirus ( HPV ) . The purpose study assess clinical effectiveness trial drug , SGN-00101 , child RRP also assess safety .</brief_summary>
	<brief_title>A Trial Study SGN-00101 Treating Pediatric Patients With Recurrent Respiratory Papillomatosis</brief_title>
	<detailed_description />
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<criteria>Male female 2 18 yr old , inclusive , documented RRP . Patients document RRP Subject surgically debulked within 7 day first dose SGN00101 . Subject least 4 debulking surgery RRP , intersurgical interval great 84 day period last 4 surgery . Subject free life threaten serious concomitant disorder disease study . Females childbearing potential must negative pregnancy test must practice effective/appropriate method birth control determine Investigator . Subject disease status cause compromise immune system . Subject history ionize radiation therapy respiratory tract . Patient use concomitant medication may suppress immune system . Subject receive specific nonspecific immunotherapy intend treatment RRP ( i.e . mumps vaccine inject intralesionally ) within 9 month prior Week 0 study . Subject participate past study SGN00101 Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>HPV</keyword>
	<keyword>Papilloma</keyword>
</DOC>